1. Home
  2. List
Search Options

5 records – page 1 of 1.

http://www.drugwatch.com/

Stockport, United Kingdom: , 2009. (Online)
Audience
Patient or Public
Agency
BC Children's and Women's
This website provides information to aid in the understanding of various medications and conditions. It includes FDA alerts, drug interactions, and potential side effects. The content on the site may help consumers formulate questions for medical professionals and it alerts the public about importa…
Title
DrugWatch.com
Place
Stockport, United Kingdom
Year Published
2009
Topics
Drugs-Directories. Resource Guides
Drug Side Effects
Abstract
This website provides information to aid in the understanding of various medications and conditions. It includes FDA alerts, drug interactions, and potential side effects. The content on the site may help consumers formulate questions for medical professionals and it alerts the public about important information regarding potentially dangerous side effects associated with certain medications.
Please note: DrugWatch.com is not an online pharmacy and should not be considered a replacement for the information provided by pharmacies. The information on the Web site is intended to serve as an additional resource only, and the content is not a substitute for the opinion of a physician or other professional.
Material Type
Online
Agency
BC Children's and Women's
URL
http://www.drugwatch.com/
Audience
Patient or Public

http://www.pedmed.org/DrugApp/index.html

Esau, Roberta (ed.). Vancouver, BC: BC Children's Hospital , 2012. 6th Ed. (Book) — 1 copy, 1 available
Audience
Professional
Agency
BC Children's and Women's
Location
Study & Learning Commons
Call Number
REF EA 22 ESA 2012
The 6th edition of the BC Children's Hospital Pediatric Drug Dosage Guidelines provides dosing information for the pediatric population (neonates, infants and older children.) Also included are immunization schedules, guidance for therapeutic drug monitoring and protocols for anticoagulant and thro…
Title
Pediatric drug dosage guidelines
Author
Esau, Roberta (ed.)
Corporate Author
Pharmacy, Therapeutics and Nutrition Committee
Edition
6th Ed.
Place
Vancouver, BC
Publisher
BC Children's Hospital
Year Published
2012
Physical Description
Spiral bound softcover: 344 p.
Topics
Pharmacist
Drug Therapy-Children
Drugs-Directories. Resource Guides
Abstract
The 6th edition of the BC Children's Hospital Pediatric Drug Dosage Guidelines provides dosing information for the pediatric population (neonates, infants and older children.) Also included are immunization schedules, guidance for therapeutic drug monitoring and protocols for anticoagulant and thrombolytic therapy. Pediatrics, pediatric residents and fellows, pharmacists, pediatric nurses and other practitioners who treat children will find the guidelines a source of information on medications in children.
Language
English
Material Type
Book
Agency
BC Children's and Women's
Location
Study & Learning Commons
URL
http://www.pedmed.org/DrugApp/index.html
Audience
Professional
Call Number
REF EA 22 ESA 2012
Copy 1 BC Children's and Women's Study & Learning Commons Available

Medications and mothers' milk: A manual of lactational pharmacology

https://libraries.phsa.ca/permalink/catalog111525
Hale, Thomas W. Amarillo, TX: Hale Publishing , 2010. 14th edition. (Book) — 1 copy, 1 available
Audience
Patient or Public
Agency
BC Children's and Women's
Location
Family Support & Resource Centre
Call Number
EA 350 HAL 2010
Comprising an alphabetical list of more that 900 drugs, diseases, vaccines and other material, this easy-to-use reference provides mothers or health professionals with recommendations about the use of medications while breastfeeding.
Title
Medications and mothers' milk: A manual of lactational pharmacology
Author
Hale, Thomas W.
Edition
14th edition
Place
Amarillo, TX
Publisher
Hale Publishing
Year Published
2010
Physical Description
Softcover: 1262 p.
Topics
Drug Side Effects
Breastfeeding
Drugs-Directories. Resource Guides
Abstract
Comprising an alphabetical list of more that 900 drugs, diseases, vaccines and other material, this easy-to-use reference provides mothers or health professionals with recommendations about the use of medications while breastfeeding.
ISBN
9780982337998
Language
English
Material Type
Book
Agency
BC Children's and Women's
Location
Family Support & Resource Centre
Audience
Patient or Public
Call Number
EA 350 HAL 2010
Copy 1 BC Children's and Women's Family Support & Resource Centre Available
thumbnail

Cancer drug manual [electronic resource]

https://libraries.phsa.ca/permalink/catalog103123

http://www.bccancer.bc.ca/HPI/DrugDatabase/default.htm

British Columbia Cancer Agency Division of Pharmacy. Vancouver, BC: British Columbia Cancer Agency , 2007. (Online)
Audience
Patient or Public
Agency
BC Children's and Women's
The information in this manual is presented to assist health care professionals caring for cancer patients undergoing treatment with cytotoxics, hormones or biological response modifiers. ; Contents: ; Actinomycin D; see Dactinomycin ; ADRIAMYCIN®; see Doxorubicin ; ADRUCIL®; see Fluorouracil ; …
Title
Cancer drug manual [electronic resource]
Corporate Author
British Columbia Cancer Agency Division of Pharmacy
Place
Vancouver, BC
Publisher
British Columbia Cancer Agency
Year Published
2007
Topics
Antineoplastics. Cancer Drugs
Drugs-Directories. Resource Guides
Cancer-Directories. Resource Guides
Drug Action. Drug Interactions. Food and Drug Interactions.
Cancer-Chemotherapy
Drug Side Effects
Abstract
The information in this manual is presented to assist health care professionals caring for cancer patients undergoing treatment with cytotoxics, hormones or biological response modifiers.
Contents:
Actinomycin D; see Dactinomycin
ADRIAMYCIN®; see Doxorubicin
ADRUCIL®; see Fluorouracil
Aldesleukin
Alemtuzumab
ALKERAN®; see Melphalan
All-trans retinoic acid; see Tretinoin
Amifostine
Aminoglutethimide
Amsacrine
Anagrelide
ANANDRON®; see Nilutamide
Anastrozole
ANDROCUR®; see Cyproterone
Ara-C; see Cytarabine
AREDIA®; see Pamidronate
ARIMIDEX®; see Anastrozole
AROMASIN®; see Exemestane
Asparaginase
Asparaginase Erwinia
AVASTIN®; see Bevacizumab
B
Bacillus Calmette-Guerin; see BCG
BCG
BCNU; see Carmustine
Bevacizumab
Bicalutamide
BiCNU®; see Carmustine
BLENOXANE®; see Bleomycin
Bleomycin
BONEFOS®; see Clodronate
Bortezomib
Bromocriptine
Buserelin
Busulfan
C
Caelyx; see Doxorubicin, pegylated liposomal
Cabergoline
Calcium folinate; see Leucovorin
Calcium leucovorin; see Leucovorin
CAMPTOSAR®; see Irinotecan
Capecitabine
Carboplatin
Carmustine
CASODEX®; see Bicalutamide
CCNU; see Lomustine
CEENU®; see Lomustine
CERUBIDINE®; see Daunorubicin
Cetuximab
Chlorambucil
Cisplatin
Cladribine
Clodronate
COSMEGAN®; see Dactinomycin
Cyclophosphamide
Cyproterone
CYTADREN®; see Aminoglutethimide
Cytarabine
CYTOSAR®; see Cytarabine
Cytosine arabinoside; see Cytarabine
CYTOXAN®; see Cyclophosphamide
D
Dacarbazine
Dactinomycin
Dasatinib
Daunorubicin
DEPO-PROVERA®; see Medroxyprogesterone
Dexamethasone
Dexrazoxane
Docetaxel
Doxorubicin
Doxorubicin pegylated liposomal
DTIC®-Dome; see Dacarbazine
E
EFUDEX® Cream; see Fluorouracil
ELOXATIN®; see Oxaliplatin
EMCYT®; see Estramustine
Epirubicin
Erlotinib
Estramustine
Etoposide
Exemestane
EUFLEX®; see Flutamide
F
FASLODEX®; see Fulvestrant
FEMARA®; see Letrozole
5-fluorouracil; see Fluorouracil
5-FU; see Fluorouracil
Filgrastim
FLORINEF®; see Fludrocortisone
FLUDARA®; see Fludarabine
Fludarabine
Fludrocortisone
Fluorouracil
Flutamide
Folinic acid; see Leucovorin
Fulvestrant
G
G-CSF; see Filgrastim
Gefitinib
Gemcitabine
GEMZAR®; see Gemcitabine
GLEEVEC®; see Imatinib
GLIVEC®; see Imatinib
Goserelin
H
HERCEPTIN®; see Trastuzumab
HYCAMTIN®; see Topotecan
HYDREA®; see Hydroxyurea
Hydroxyurea
I
Ibritumomab
IDAMYCIN®; see Idarubicin
Idarubicin
IFEX®; see Ifosfamide
IFN; see Interferon alfa-2b
Ifosfamide
Imatinib
IMMUCYST® BCG Therapeutic; see BCG
Interferon alfa-2b
INTRON-A® (alfa-2b); see Interferon alfa-2b
IRESSA®; see Gefitinib
Irinotecan
J
K
Kidrolase; see Asparaginase
L
Lanreotide
LANVIS®; see Thioguanine
L-asparaginase; see Asparaginase
LEDERLE LEUCOVORIN CALCIUM®; see Leucovorin
Letrozole
Leucovorin
LEUKERAN®; see Chlorambucil
Leuprolide
LEUSTATIN®; see Cladribine
Lomustine
LUPRON®; see Leuprolide
LYSODREN®; see Mitotane
M
Mechlorethamine
Medroxyprogesterone
MEGACE®; see Megestrol
Megestrol
Melphalan
Mercaptopurine
Mesna
Methotrexate
Mitomycin
Mitotane
Mitoxantrone
MTX; see Methotrexate
MUSTARGEN®; see Mechlorethamine
MUTAMYCIN®; see Mitomycin
Myleran; see Busulfan
N
NATULAN®; see Procarbazine
NAVELBINE®; see Vinorelbine
NEXAVAR®; see Sorafenib
Nilutamide
NIPENT®; see Pentostatin
Nitrogen Mustard; see Mechlorethamine
NOLVADEX®; see Tamoxifen
NOLVADEX-D®; see Tamoxifen
NOVANTRONE®; see Mitoxantrone
Novo-tamoxifen; see Tamoxifen
NUPOGEN®; see Filgrastim
O
Octreotide
ONCOVIN®; see Vincristine
OSTAC®; see Clodronate
Oxaliplatin
P
Paclitaxel; nanoparticle, albumin-bound (nab)
Pamidronate
PARAPLATIN®; see Carboplatin
PARAPLATIN AQ®; see Carboplatin
Pemetrexed
PHARMORUBICIN® PFS; see Epirubicin
PHARMORUBICIN® RDF; see Epirubicin
PHOTOFRIN®; see Porfimer
PLATINOL-AQ®; see Cisplatin
Platinum; see Cisplatin
Porfimer
Procarbazine
PROCYTOX®; see Cyclophosphamide
PROVERA®; see Medroxyprogesterone
PURINETHOL®; see Mercaptopurine
R
Raltitrexed
ROFERON A® (alfa 2a); see Interferon Alfa
RITUXAN®; see Rituximab
Rituximab
S
SANDOSTATIN®, SANDOSTATIN LAR®; see Octreotide
Somatostatin analogue; see Octreotide
SOMATULINE®; see Lanreotide
Sorafenib
Streptozocin
Sunitinib
SUTENT®; see Sunitinib
SUPREFACT®; see Buserelin
T
TAMOFEN®; see Tamoxifen
Tamoxifen
TARCEVA®; see Erlotinib
TAXOL®; see Paclitaxel
TAXOTERE®; see Docetaxel
TEMODAL®; see Temozolomide
Temozolomide
Temsirolimus
Teniposide
Testosterone
Thalidomide
TheraCys; see BCG
Thioguanine
Thiotepa
Thyrotropin alfa
Tice BCG; see BCG
TOMUDEX®; see Raltitrexed
Topotecan
Tositumomab
Trastuzumab
Tretinoin
U
UROMITEXAN®; see Mesna
Users Guide to the Cancer Drug Manual
V
VELBE®; see Vinblastine
VELCADE®; see Bortezomib
VEPESID®; see Etoposide
VESANOID®; see Tretinoin
Vinblastine
Vincristine
Vinorelbine
VUMON®; see Teniposide
W
WELLCOVORIN®; see Leucovorin
WELLFERON® (alfa n1); see Interferon Alfa
X
XELODA®; see Capecitabine
Z
ZANOSAR®; see Streptozocin
ZINECARD®; see Dexrazoxane
ZOLADEX®; see Goserelin
Material Type
Online
Agency
BC Children's and Women's
URL
http://www.bccancer.bc.ca/HPI/DrugDatabase/default.htm
Audience
Patient or Public

http://medlineplus.gov/

US National Library of Medicine, National Institute of Health. Bethesda, MD: US National Library of Medicine (Online)
Audience
Patient or Public
Agency
BC Children's and Women's
MedlinePlus brings together authoritative consumer health information from the NLM, the National Institutes of Health (NIH), and other U.S. government agencies and health-related organizations. Preformulated MEDLINE searches are included in MedlinePlus and give easy access to medical journal articl…
Title
MedlinePlus
Subtitle
Trusted health information for you
Corporate Author
US National Library of Medicine
National Institute of Health
Place
Bethesda, MD
Publisher
US National Library of Medicine
Topics
Medical/Health Information on the Internet
Medical Directories. Resource Guides
Medical Encyclopedias
Drugs-Directories. Resource Guides
Patient Education
Abstract
MedlinePlus brings together authoritative consumer health information from the NLM, the National Institutes of Health (NIH), and other U.S. government agencies and health-related organizations. Preformulated MEDLINE searches are included in MedlinePlus and give easy access to medical journal articles. MedlinePlus also has extensive patient-level information about drugs, an illustrated medical encyclopedia, interactive patient tutorials, and latest health news.
Material Type
Online
Agency
BC Children's and Women's
URL
http://medlineplus.gov/
Audience
Patient or Public